(Adds comment from Jarden note, updates share moves)

** Brokerages slash PT and outlook for technical services provider ALS on weak H1 forecast

** Macquarie slashes PT by 7% to A$15, reduces FY25, 26 and 27 EPS estimates by 9%, 7% and 7%, respectively

** Expects co's exploration cycle to show recovery in CY25 after 2 down years, supported by a gradually improving economic activity post Fed's rate cuts

** Morningstar cuts FY25 net profit after tax (NPAT) forecast by 5% to A$295 mln ($201 mln), sees limited longer-term implications despite outlook downgrade

** Jarden lowers PT to A$14.20 from A$14.90, sees 7% decline in H1 core NPAT and 1% drop in FY25 core NPAT

** ALS up 2% at A$13.940

** Stock dropped 8.6% in its worst day in more than 4 years on Thursday as co expected a 5% reduction in HY underlying NPAT

** Stock gains 8.3% YTD

($1 = A$1.4671)

(Reporting by Ayushman Ojha in Bengaluru)

((Ayushman.ojha@thomsonreuters.com;))